Relationship between somatostatin receptor expressing tumour volume and health‐related quality of life in patients with metastatic GEP‐NET

For patients with gastroenteropancreatic neuroendocrine tumours (GEP‐NET), health‐related quality of life (HRQoL) is important. Meanwhile, whether tumour volume is associated with HRQoL is unknown. Hence, the aim of this study was to assess if total somatostatin receptor expressing tumour volume is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohlsson, Håkan, Gålne, Anni, Trägårdh, Elin, Malmström, Marlene, Sundlöv, Anna, Almquist, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Translational and Clinical Neuroendocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285792/
https://www.ncbi.nlm.nih.gov/pubmed/35488399
http://dx.doi.org/10.1111/jne.13139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285792/
https://www.ncbi.nlm.nih.gov/pubmed/35488399
http://dx.doi.org/10.1111/jne.13139

Ejemplares similares